

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 6.31309104 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.95744690 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.95744690 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.66107801 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.49232454 |
| 6 | muscle filament sliding (GO:0030049) | 5.28153414 |
| 7 | actin-myosin filament sliding (GO:0033275) | 5.28153414 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.17039124 |
| 9 | myofibril assembly (GO:0030239) | 4.98634025 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.89145579 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.80539326 |
| 12 | regulation of skeletal muscle contraction (GO:0014819) | 4.61478916 |
| 13 | interkinetic nuclear migration (GO:0022027) | 4.59177788 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.59060082 |
| 15 | sarcomere organization (GO:0045214) | 4.56062655 |
| 16 | actin-mediated cell contraction (GO:0070252) | 4.52090952 |
| 17 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.51552027 |
| 18 | regulation of relaxation of muscle (GO:1901077) | 4.46824016 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.42531137 |
| 20 | regulation of RIG-I signaling pathway (GO:0039535) | 4.31873003 |
| 21 | skeletal muscle adaptation (GO:0043501) | 4.24829333 |
| 22 | natural killer cell mediated immunity (GO:0002228) | 4.24372162 |
| 23 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.24372162 |
| 24 | cardiac myofibril assembly (GO:0055003) | 4.22774666 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04000018 |
| 26 | negative regulation of cell killing (GO:0031342) | 4.04000018 |
| 27 | myeloid dendritic cell differentiation (GO:0043011) | 3.99933394 |
| 28 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.99778805 |
| 29 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.99022879 |
| 30 | neutrophil activation (GO:0042119) | 3.98615558 |
| 31 | behavioral response to nicotine (GO:0035095) | 3.97586340 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95217432 |
| 33 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.91614360 |
| 34 | granulocyte activation (GO:0036230) | 3.90353830 |
| 35 | positive regulation of antigen processing and presentation (GO:0002579) | 3.89761812 |
| 36 | tryptophan catabolic process (GO:0006569) | 3.89701059 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 3.89701059 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 3.89701059 |
| 39 | striated muscle atrophy (GO:0014891) | 3.89606282 |
| 40 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.83856555 |
| 41 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.80529963 |
| 42 | regulation of cell communication by electrical coupling (GO:0010649) | 3.75635119 |
| 43 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.67767108 |
| 44 | response to inactivity (GO:0014854) | 3.63826610 |
| 45 | striated muscle contraction (GO:0006941) | 3.61143932 |
| 46 | macroautophagy (GO:0016236) | 3.58034740 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57620582 |
| 48 | myeloid dendritic cell activation (GO:0001773) | 3.56327649 |
| 49 | negative thymic T cell selection (GO:0045060) | 3.56240065 |
| 50 | growth hormone receptor signaling pathway (GO:0060396) | 3.55552406 |
| 51 | response to caffeine (GO:0031000) | 3.55378251 |
| 52 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.54126942 |
| 53 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.53605183 |
| 54 | necroptotic process (GO:0070266) | 3.53401352 |
| 55 | cellular response to type I interferon (GO:0071357) | 3.52960753 |
| 56 | type I interferon signaling pathway (GO:0060337) | 3.52960753 |
| 57 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.50592835 |
| 58 | response to type I interferon (GO:0034340) | 3.50586174 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 3.48305810 |
| 60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.45479321 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45013796 |
| 62 | membrane depolarization during action potential (GO:0086010) | 3.44604105 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.41186732 |
| 64 | negative regulation of protein localization to cell surface (GO:2000009) | 3.40978548 |
| 65 | cardiac muscle contraction (GO:0060048) | 3.39951305 |
| 66 | actomyosin structure organization (GO:0031032) | 3.39823095 |
| 67 | regulation of hypersensitivity (GO:0002883) | 3.39396984 |
| 68 | regulation of sarcomere organization (GO:0060297) | 3.38229908 |
| 69 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.37785466 |
| 70 | positive regulation of interferon-alpha production (GO:0032727) | 3.37132477 |
| 71 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.36607172 |
| 72 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.35942313 |
| 73 | negative T cell selection (GO:0043383) | 3.34260409 |
| 74 | positive regulation of interleukin-12 production (GO:0032735) | 3.31456713 |
| 75 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.30579971 |
| 76 | regulation of striated muscle contraction (GO:0006942) | 3.30065805 |
| 77 | fatty acid transmembrane transport (GO:1902001) | 3.29795788 |
| 78 | positive regulation by symbiont of host defense response (GO:0052509) | 3.27964906 |
| 79 | modulation by symbiont of host defense response (GO:0052031) | 3.27964906 |
| 80 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.27964906 |
| 81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.27964906 |
| 82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.27964906 |
| 83 | modulation by symbiont of host immune response (GO:0052553) | 3.27964906 |
| 84 | dendritic cell differentiation (GO:0097028) | 3.27591718 |
| 85 | L-fucose catabolic process (GO:0042355) | 3.26726275 |
| 86 | fucose catabolic process (GO:0019317) | 3.26726275 |
| 87 | L-fucose metabolic process (GO:0042354) | 3.26726275 |
| 88 | regulation of response to interferon-gamma (GO:0060330) | 3.24924571 |
| 89 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.23815050 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 3.23567139 |
| 91 | B cell mediated immunity (GO:0019724) | 3.20871539 |
| 92 | tryptophan metabolic process (GO:0006568) | 3.18895658 |
| 93 | regulation of interferon-alpha production (GO:0032647) | 3.18863705 |
| 94 | skeletal muscle contraction (GO:0003009) | 3.17661166 |
| 95 | T-helper 1 type immune response (GO:0042088) | 3.16560305 |
| 96 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.16246625 |
| 97 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.15251524 |
| 98 | indolalkylamine metabolic process (GO:0006586) | 3.14682160 |
| 99 | muscle atrophy (GO:0014889) | 3.14591093 |
| 100 | positive regulation of humoral immune response (GO:0002922) | 3.14376206 |
| 101 | cardiac muscle hypertrophy (GO:0003300) | 3.14233422 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 3.14081428 |
| 103 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.13306282 |
| 104 | regulation of actin filament-based movement (GO:1903115) | 3.12944866 |
| 105 | relaxation of cardiac muscle (GO:0055119) | 3.11143094 |
| 106 | actin filament-based movement (GO:0030048) | 3.05608751 |
| 107 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.04292748 |
| 108 | ketone body metabolic process (GO:1902224) | 3.03447450 |
| 109 | regulation of membrane repolarization (GO:0060306) | 3.03340837 |
| 110 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.03253606 |
| 111 | leukocyte mediated cytotoxicity (GO:0001909) | 3.01977951 |
| 112 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.98302675 |
| 113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.98277270 |
| 114 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.97440827 |
| 115 | striated muscle hypertrophy (GO:0014897) | 2.97106176 |
| 116 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.96823245 |
| 117 | negative regulation of interleukin-17 production (GO:0032700) | 2.95748122 |
| 118 | regulation of necroptotic process (GO:0060544) | 2.94465767 |
| 119 | cellular response to growth hormone stimulus (GO:0071378) | 2.94267842 |
| 120 | regulation of B cell differentiation (GO:0045577) | 2.92794103 |
| 121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.92260126 |
| 122 | natural killer cell differentiation (GO:0001779) | 2.91498428 |
| 123 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.91113906 |
| 124 | T cell migration (GO:0072678) | 2.90933613 |
| 125 | positive regulation of cation channel activity (GO:2001259) | 2.90768065 |
| 126 | muscle contraction (GO:0006936) | 2.89285313 |
| 127 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.89192375 |
| 128 | T-helper cell differentiation (GO:0042093) | 2.89192375 |
| 129 | regulation of energy homeostasis (GO:2000505) | 2.89166155 |
| 130 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.88019757 |
| 131 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.88019757 |
| 132 | positive regulation of T cell cytokine production (GO:0002726) | 2.87956405 |
| 133 | regulation of establishment of cell polarity (GO:2000114) | 2.86539985 |
| 134 | oxidative demethylation (GO:0070989) | 2.85884520 |
| 135 | regulation of hippo signaling (GO:0035330) | 2.84890061 |
| 136 | mature B cell differentiation (GO:0002335) | 2.84168018 |
| 137 | respiratory burst (GO:0045730) | 2.83241727 |
| 138 | regulation of the force of heart contraction (GO:0002026) | 2.83136917 |
| 139 | regulation of natural killer cell differentiation (GO:0032823) | 2.82644237 |
| 140 | positive regulation of interleukin-2 production (GO:0032743) | 2.81019133 |
| 141 | cAMP catabolic process (GO:0006198) | 2.80962862 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78618155 |
| 143 | response to peptidoglycan (GO:0032494) | 2.78425063 |
| 144 | positive regulation of interferon-beta production (GO:0032728) | 2.77411063 |
| 145 | striated muscle adaptation (GO:0014888) | 2.77050440 |
| 146 | regulation of interleukin-12 production (GO:0032655) | 2.76788267 |
| 147 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.75777821 |
| 148 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.75399846 |
| 149 | detection of light stimulus involved in visual perception (GO:0050908) | 2.75399846 |
| 150 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.74729679 |
| 151 | cellular response to zinc ion (GO:0071294) | 2.74601538 |
| 152 | muscle system process (GO:0003012) | 2.74386891 |
| 153 | lymphocyte mediated immunity (GO:0002449) | 2.74316049 |
| 154 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.74309725 |
| 155 | carnitine shuttle (GO:0006853) | 2.73962306 |
| 156 | neuronal action potential (GO:0019228) | 2.73834612 |
| 157 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.73479689 |
| 158 | response to interleukin-15 (GO:0070672) | 2.73362748 |
| 159 | cytokine secretion (GO:0050663) | 2.73355875 |
| 160 | cardiac muscle cell development (GO:0055013) | 2.72584426 |
| 161 | myeloid cell activation involved in immune response (GO:0002275) | 2.72031875 |
| 162 | positive regulation of fatty acid oxidation (GO:0046321) | 2.71505688 |
| 163 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.71331800 |
| 164 | indole-containing compound metabolic process (GO:0042430) | 2.70754635 |
| 165 | actin nucleation (GO:0045010) | 2.70101691 |
| 166 | response to muramyl dipeptide (GO:0032495) | 2.70094354 |
| 167 | NAD biosynthetic process (GO:0009435) | 2.68752706 |
| 168 | natural killer cell activation (GO:0030101) | 2.68499069 |
| 169 | muscle fiber development (GO:0048747) | 2.66742826 |
| 170 | neuronal action potential propagation (GO:0019227) | 2.66684909 |
| 171 | adult heart development (GO:0007512) | 2.66564818 |
| 172 | muscle hypertrophy (GO:0014896) | 2.66454021 |
| 173 | regulation of T cell tolerance induction (GO:0002664) | 2.65922796 |
| 174 | regulation of cardiac muscle contraction (GO:0055117) | 2.65867291 |
| 175 | response to interferon-gamma (GO:0034341) | 2.65789753 |
| 176 | lymphocyte migration (GO:0072676) | 2.65014194 |
| 177 | primary amino compound metabolic process (GO:1901160) | 2.64959146 |
| 178 | cyclic nucleotide catabolic process (GO:0009214) | 2.64927865 |
| 179 | pericardium development (GO:0060039) | 2.64240477 |
| 180 | positive regulation of protein homooligomerization (GO:0032464) | 2.63295222 |
| 181 | leukocyte degranulation (GO:0043299) | 2.63145914 |
| 182 | regulation of action potential (GO:0098900) | 2.62965027 |
| 183 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.62782869 |
| 184 | establishment of protein localization to Golgi (GO:0072600) | 2.61306136 |
| 185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61289508 |
| 186 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.60189387 |
| 187 | regulation of immunoglobulin secretion (GO:0051023) | 2.59829435 |
| 188 | defense response to protozoan (GO:0042832) | 2.59826928 |
| 189 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.59627388 |
| 190 | carnitine transmembrane transport (GO:1902603) | 2.57957968 |
| 191 | protein K63-linked deubiquitination (GO:0070536) | 2.56393415 |
| 192 | nucleus localization (GO:0051647) | 2.56041620 |
| 193 | plasma membrane repair (GO:0001778) | 2.55857501 |
| 194 | serotonin metabolic process (GO:0042428) | 2.55795080 |
| 195 | skeletal muscle tissue regeneration (GO:0043403) | 2.53292694 |
| 196 | muscle tissue morphogenesis (GO:0060415) | 2.53258983 |
| 197 | protein K11-linked deubiquitination (GO:0035871) | 2.52000206 |
| 198 | positive regulation of heart rate (GO:0010460) | 2.51285081 |
| 199 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.50897731 |
| 200 | histone-serine phosphorylation (GO:0035404) | 2.49830843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.08442443 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.96043388 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.27200980 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.74434997 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.41021223 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.29593799 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.26456924 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.23220491 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17535344 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.12043584 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.09151700 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07302622 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05998818 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01560548 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.92454523 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.88587255 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71800569 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.71703038 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.66187557 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.63199528 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62913026 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59606799 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.59466724 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.57411895 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.56635372 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.44256222 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36957421 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.34568251 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.23848227 |
| 30 | * MYB_26560356_Chip-Seq_TH2_Human | 2.22414572 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.21018018 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17670718 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.15934680 |
| 34 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13813553 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.11940574 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.05878012 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.02433927 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02380410 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99219105 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94565008 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94406684 |
| 42 | * MAF_26560356_Chip-Seq_TH1_Human | 1.91120823 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.89758847 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88596666 |
| 45 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86489394 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.85336249 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.83808935 |
| 48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.82938551 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82107064 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78773220 |
| 51 | TP53_16413492_ChIP-PET_HCT116_Human | 1.76078912 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.75437636 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.74791604 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.74129738 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.73082037 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72080280 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65702277 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64615615 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64604592 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64230680 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.61762904 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.61364699 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60935748 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60834789 |
| 65 | TCF4_23295773_ChIP-Seq_U87_Human | 1.58677364 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58009059 |
| 67 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57137768 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56647582 |
| 69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.56093344 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54850389 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49023659 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48869901 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48802189 |
| 74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46846591 |
| 75 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.46342668 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45824804 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44427011 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44037696 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43165094 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42802256 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41305283 |
| 82 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40978334 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40534879 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39056819 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39040784 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38030256 |
| 87 | EWS_26573619_Chip-Seq_HEK293_Human | 1.37758062 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37001675 |
| 89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36693961 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36646050 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36171510 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36052078 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35852299 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35457593 |
| 95 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35411225 |
| 96 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.34616331 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34347446 |
| 98 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33992681 |
| 99 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33820484 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33402868 |
| 101 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.33104021 |
| 102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32677363 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32670334 |
| 104 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31253736 |
| 105 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.30580312 |
| 106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30345281 |
| 107 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30148114 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.29407579 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28511353 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27517163 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.27478746 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25586300 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25477348 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22548885 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22479970 |
| 116 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22236794 |
| 117 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22236794 |
| 118 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21616770 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21204230 |
| 120 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20797606 |
| 121 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20797606 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20350802 |
| 123 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.20350802 |
| 124 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.19019817 |
| 125 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18427353 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17863210 |
| 127 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16917695 |
| 128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16896937 |
| 129 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16642667 |
| 130 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.16382149 |
| 131 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15973583 |
| 132 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15969373 |
| 133 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14542763 |
| 134 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13621532 |
| 135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12459131 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11808168 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11494577 |
| 138 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.10297937 |
| 139 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10004214 |
| 140 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09835445 |
| 141 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09581974 |
| 142 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09165559 |
| 143 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08854756 |
| 144 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08341287 |
| 145 | MAF_26560356_Chip-Seq_TH2_Human | 1.07862348 |
| 146 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07821673 |
| 147 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07614812 |
| 148 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06571691 |
| 149 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06467386 |
| 150 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06429061 |
| 151 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06061810 |
| 152 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05503459 |
| 153 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05317973 |
| 154 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.05157167 |
| 155 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04478485 |
| 156 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03387864 |
| 157 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03198729 |
| 158 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03188722 |
| 159 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03087400 |
| 160 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02044641 |
| 161 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01615512 |
| 162 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01382175 |
| 163 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00803241 |
| 164 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00266924 |
| 165 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00266924 |
| 166 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00110684 |
| 167 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99886008 |
| 168 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99344767 |
| 169 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98847020 |
| 170 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98763258 |
| 171 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97817079 |
| 172 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97135406 |
| 173 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97128584 |
| 174 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96273639 |
| 175 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.95634972 |
| 176 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94420986 |
| 177 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90140683 |
| 178 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88779586 |
| 179 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86106186 |
| 180 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85535269 |
| 181 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84318374 |
| 182 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82560234 |
| 183 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.82442901 |
| 184 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81392552 |
| 185 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81086190 |
| 186 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.79149363 |
| 187 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78876438 |
| 188 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76797757 |
| 189 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74127826 |
| 190 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.71143432 |
| 191 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70783009 |
| 192 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.69646715 |
| 193 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.69018041 |
| 194 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68606156 |
| 195 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.68434469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 4.49549922 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.25745083 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.21941075 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.09550412 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 3.93755164 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.64163076 |
| 7 | MP0000685_abnormal_immune_system | 3.42202608 |
| 8 | MP0004130_abnormal_muscle_cell | 3.35798264 |
| 9 | MP0004215_abnormal_myocardial_fiber | 3.17047038 |
| 10 | MP0003436_decreased_susceptibility_to | 3.09960015 |
| 11 | MP0009785_altered_susceptibility_to | 3.09019449 |
| 12 | MP0000749_muscle_degeneration | 3.06810713 |
| 13 | MP0000751_myopathy | 2.92279389 |
| 14 | MP0001790_abnormal_immune_system | 2.88153997 |
| 15 | MP0005387_immune_system_phenotype | 2.88153997 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.85346170 |
| 17 | MP0005671_abnormal_response_to | 2.81450136 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.80393432 |
| 19 | MP0002254_reproductive_system_inflammat | 2.76761311 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.59275851 |
| 21 | MP0001800_abnormal_humoral_immune | 2.56616359 |
| 22 | MP0004510_myositis | 2.54443117 |
| 23 | MP0002163_abnormal_gland_morphology | 2.50680774 |
| 24 | MP0005620_abnormal_muscle_contractility | 2.46391206 |
| 25 | MP0002723_abnormal_immune_serum | 2.44809823 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.40662150 |
| 27 | MP0005025_abnormal_response_to | 2.36127659 |
| 28 | MP0002332_abnormal_exercise_endurance | 2.32700526 |
| 29 | MP0005310_abnormal_salivary_gland | 2.32282518 |
| 30 | MP0009840_abnormal_foam_cell | 2.31467064 |
| 31 | MP0001819_abnormal_immune_cell | 2.26616264 |
| 32 | MP0002419_abnormal_innate_immunity | 2.25981981 |
| 33 | MP0002420_abnormal_adaptive_immunity | 2.24140095 |
| 34 | MP0002106_abnormal_muscle_physiology | 2.18984819 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 2.18718240 |
| 36 | MP0003303_peritoneal_inflammation | 2.13094053 |
| 37 | MP0002166_altered_tumor_susceptibility | 2.12917440 |
| 38 | MP0008775_abnormal_heart_ventricle | 2.11510844 |
| 39 | MP0004043_abnormal_pH_regulation | 2.05158385 |
| 40 | MP0009046_muscle_twitch | 2.05072421 |
| 41 | MP0005058_abnormal_lysosome_morphology | 2.04593966 |
| 42 | MP0001348_abnormal_lacrimal_gland | 2.04288104 |
| 43 | MP0004484_altered_response_of | 2.04146592 |
| 44 | MP0003950_abnormal_plasma_membrane | 2.01365325 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.92786961 |
| 46 | MP0000750_abnormal_muscle_regeneration | 1.91031720 |
| 47 | MP0005369_muscle_phenotype | 1.87503809 |
| 48 | MP0005379_endocrine/exocrine_gland_phen | 1.87439415 |
| 49 | MP0002398_abnormal_bone_marrow | 1.87116616 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.86259821 |
| 51 | MP0006082_CNS_inflammation | 1.84719960 |
| 52 | MP0004947_skin_inflammation | 1.84605533 |
| 53 | MP0000716_abnormal_immune_system | 1.84100250 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.80284192 |
| 55 | MP0003137_abnormal_impulse_conducting | 1.78648836 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.75498971 |
| 57 | MP0002006_tumorigenesis | 1.75361076 |
| 58 | MP0001853_heart_inflammation | 1.73216251 |
| 59 | MP0009745_abnormal_behavioral_response | 1.68772243 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.68571958 |
| 61 | MP0002269_muscular_atrophy | 1.67566806 |
| 62 | MP0001501_abnormal_sleep_pattern | 1.67217874 |
| 63 | MP0005330_cardiomyopathy | 1.66869608 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.66214216 |
| 65 | MP0000427_abnormal_hair_cycle | 1.61824641 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.60275029 |
| 67 | MP0002405_respiratory_system_inflammati | 1.58452349 |
| 68 | MP0003724_increased_susceptibility_to | 1.57889006 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.55862865 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.55837449 |
| 71 | MP0004085_abnormal_heartbeat | 1.54392389 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.51113757 |
| 73 | MP0002429_abnormal_blood_cell | 1.49080977 |
| 74 | MP0003045_fibrosis | 1.48903893 |
| 75 | MP0000747_muscle_weakness | 1.48388888 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.47960168 |
| 77 | MP0008469_abnormal_protein_level | 1.47897661 |
| 78 | MP0002722_abnormal_immune_system | 1.47846079 |
| 79 | MP0000759_abnormal_skeletal_muscle | 1.46926658 |
| 80 | MP0002693_abnormal_pancreas_physiology | 1.44376725 |
| 81 | MP0005266_abnormal_metabolism | 1.43478602 |
| 82 | MP0004142_abnormal_muscle_tone | 1.42638989 |
| 83 | MP0003300_gastrointestinal_ulcer | 1.42480883 |
| 84 | MP0002396_abnormal_hematopoietic_system | 1.38453186 |
| 85 | MP0001986_abnormal_taste_sensitivity | 1.36393027 |
| 86 | MP0009333_abnormal_splenocyte_physiolog | 1.36177244 |
| 87 | MP0001533_abnormal_skeleton_physiology | 1.33560289 |
| 88 | MP0001968_abnormal_touch/_nociception | 1.32027114 |
| 89 | MP0001873_stomach_inflammation | 1.31707285 |
| 90 | MP0002127_abnormal_cardiovascular_syste | 1.31023188 |
| 91 | MP0000604_amyloidosis | 1.30426767 |
| 92 | MP0001544_abnormal_cardiovascular_syste | 1.30299871 |
| 93 | MP0005385_cardiovascular_system_phenoty | 1.30299871 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 1.29739299 |
| 95 | MP0006138_congestive_heart_failure | 1.28926631 |
| 96 | MP0005386_behavior/neurological_phenoty | 1.26073052 |
| 97 | MP0004924_abnormal_behavior | 1.26073052 |
| 98 | MP0002064_seizures | 1.23095578 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 1.23049542 |
| 100 | MP0003183_abnormal_peptide_metabolism | 1.22879906 |
| 101 | MP0004147_increased_porphyrin_level | 1.22798628 |
| 102 | MP0002272_abnormal_nervous_system | 1.22204736 |
| 103 | MP0010307_abnormal_tumor_latency | 1.17112115 |
| 104 | MP0008961_abnormal_basal_metabolism | 1.16927742 |
| 105 | MP0002108_abnormal_muscle_morphology | 1.16663305 |
| 106 | MP0000230_abnormal_systemic_arterial | 1.16491662 |
| 107 | MP0002102_abnormal_ear_morphology | 1.14586499 |
| 108 | MP0008877_abnormal_DNA_methylation | 1.13713563 |
| 109 | MP0002009_preneoplasia | 1.13656587 |
| 110 | MP0003448_altered_tumor_morphology | 1.12894841 |
| 111 | MP0005397_hematopoietic_system_phenotyp | 1.12093450 |
| 112 | MP0001545_abnormal_hematopoietic_system | 1.12093450 |
| 113 | MP0008872_abnormal_physiological_respon | 1.11802983 |
| 114 | MP0001346_abnormal_lacrimal_gland | 1.11309920 |
| 115 | MP0004233_abnormal_muscle_weight | 1.10577343 |
| 116 | MP0010352_gastrointestinal_tract_polyps | 1.10523442 |
| 117 | MP0000703_abnormal_thymus_morphology | 1.08169775 |
| 118 | MP0009764_decreased_sensitivity_to | 1.07483095 |
| 119 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05435481 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 1.03009583 |
| 121 | MP0003866_abnormal_defecation | 1.02688510 |
| 122 | MP0002638_abnormal_pupillary_reflex | 0.99492057 |
| 123 | MP0009780_abnormal_chondrocyte_physiolo | 0.98896160 |
| 124 | MP0003635_abnormal_synaptic_transmissio | 0.97363766 |
| 125 | MP0002067_abnormal_sensory_capabilities | 0.94666231 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.94056260 |
| 127 | MP0003186_abnormal_redox_activity | 0.91705397 |
| 128 | MP0001486_abnormal_startle_reflex | 0.90054676 |
| 129 | MP0004808_abnormal_hematopoietic_stem | 0.88586791 |
| 130 | MP0003656_abnormal_erythrocyte_physiolo | 0.87839316 |
| 131 | MP0002063_abnormal_learning/memory/cond | 0.87822391 |
| 132 | MP0002736_abnormal_nociception_after | 0.86839112 |
| 133 | MP0010630_abnormal_cardiac_muscle | 0.85632096 |
| 134 | MP0000609_abnormal_liver_physiology | 0.85327136 |
| 135 | MP0000013_abnormal_adipose_tissue | 0.84973435 |
| 136 | MP0002735_abnormal_chemical_nociception | 0.84454056 |
| 137 | MP0008260_abnormal_autophagy | 0.83955665 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.83825912 |
| 139 | MP0000858_altered_metastatic_potential | 0.82958872 |
| 140 | MP0000383_abnormal_hair_follicle | 0.82797676 |
| 141 | MP0002572_abnormal_emotion/affect_behav | 0.82572709 |
| 142 | MP0005174_abnormal_tail_pigmentation | 0.81146767 |
| 143 | MP0005423_abnormal_somatic_nervous | 0.79579473 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.78892662 |
| 145 | MP0006276_abnormal_autonomic_nervous | 0.78876000 |
| 146 | MP0000490_abnormal_crypts_of | 0.78365943 |
| 147 | MP0008057_abnormal_DNA_replication | 0.77644501 |
| 148 | MP0001881_abnormal_mammary_gland | 0.76274256 |
| 149 | MP0005503_abnormal_tendon_morphology | 0.76248469 |
| 150 | MP0005645_abnormal_hypothalamus_physiol | 0.75234792 |
| 151 | MP0003252_abnormal_bile_duct | 0.74836569 |
| 152 | MP0002734_abnormal_mechanical_nocicepti | 0.74218240 |
| 153 | MP0005646_abnormal_pituitary_gland | 0.73231990 |
| 154 | MP0009763_increased_sensitivity_to | 0.72924092 |
| 155 | MP0000343_altered_response_to | 0.72734244 |
| 156 | MP0002139_abnormal_hepatobiliary_system | 0.72006132 |
| 157 | MP0002019_abnormal_tumor_incidence | 0.70702180 |
| 158 | MP0005253_abnormal_eye_physiology | 0.70454803 |
| 159 | MP0003693_abnormal_embryo_hatching | 0.69313046 |
| 160 | MP0002998_abnormal_bone_remodeling | 0.68242425 |
| 161 | MP0006036_abnormal_mitochondrial_physio | 0.67179256 |
| 162 | MP0005187_abnormal_penis_morphology | 0.67087297 |
| 163 | MP0003646_muscle_fatigue | 0.66692556 |
| 164 | MP0005670_abnormal_white_adipose | 0.66690461 |
| 165 | MP0001765_abnormal_ion_homeostasis | 0.66406704 |
| 166 | MP0001970_abnormal_pain_threshold | 0.66265773 |
| 167 | MP0003453_abnormal_keratinocyte_physiol | 0.64900473 |
| 168 | MP0002933_joint_inflammation | 0.64866748 |
| 169 | MP0004270_analgesia | 0.64731901 |
| 170 | MP0009384_cardiac_valve_regurgitation | 0.64052713 |
| 171 | MP0002168_other_aberrant_phenotype | 0.63062419 |
| 172 | MP0002733_abnormal_thermal_nociception | 0.62040409 |
| 173 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61527348 |
| 174 | MP0001485_abnormal_pinna_reflex | 0.61193366 |
| 175 | MP0001944_abnormal_pancreas_morphology | 0.61058400 |
| 176 | MP0000371_diluted_coat_color | 0.60344515 |
| 177 | MP0004885_abnormal_endolymph | 0.60258181 |
| 178 | MP0003075_altered_response_to | 0.60161421 |
| 179 | MP0005448_abnormal_energy_balance | 0.60056892 |
| 180 | MP0000465_gastrointestinal_hemorrhage | 0.59476486 |
| 181 | MP0005319_abnormal_enzyme/_coenzyme | 0.59220708 |
| 182 | MP0000733_abnormal_muscle_development | 0.59106596 |
| 183 | MP0009643_abnormal_urine_homeostasis | 0.58686694 |
| 184 | MP0005621_abnormal_cell_physiology | 0.57896198 |
| 185 | MP0001661_extended_life_span | 0.57706886 |
| 186 | MP0005535_abnormal_body_temperature | 0.57675002 |
| 187 | MP0003195_calcinosis | 0.57574159 |
| 188 | MP0002136_abnormal_kidney_physiology | 0.57480124 |
| 189 | MP0003879_abnormal_hair_cell | 0.57073530 |
| 190 | MP0000598_abnormal_liver_morphology | 0.55796550 |
| 191 | MP0003828_pulmonary_edema | 0.55316464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 4.85612102 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.76070411 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 4.74843256 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.65527660 |
| 5 | Bundle branch block (HP:0011710) | 4.55558774 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.22992024 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.21620747 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 3.95537472 |
| 9 | Increased IgM level (HP:0003496) | 3.89232531 |
| 10 | Chronic otitis media (HP:0000389) | 3.87977768 |
| 11 | Sudden death (HP:0001699) | 3.87441347 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 3.86424819 |
| 13 | Exercise-induced myalgia (HP:0003738) | 3.76757864 |
| 14 | Abnormality of alanine metabolism (HP:0010916) | 3.76355352 |
| 15 | Hyperalaninemia (HP:0003348) | 3.76355352 |
| 16 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.76355352 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.69924529 |
| 18 | Recurrent viral infections (HP:0004429) | 3.67138182 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.62727440 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.59569042 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.57725095 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.52780659 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.44787773 |
| 24 | Hyperventilation (HP:0002883) | 3.44596448 |
| 25 | Atrial fibrillation (HP:0005110) | 3.43307104 |
| 26 | Myositis (HP:0100614) | 3.37497759 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.29263973 |
| 28 | Genetic anticipation (HP:0003743) | 3.26541659 |
| 29 | Exercise-induced muscle cramps (HP:0003710) | 3.25941402 |
| 30 | Pancreatic cysts (HP:0001737) | 3.25122301 |
| 31 | Tetraparesis (HP:0002273) | 3.21648627 |
| 32 | Muscle fiber splitting (HP:0003555) | 3.17184198 |
| 33 | Primary atrial arrhythmia (HP:0001692) | 3.15608569 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 3.15291046 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.14035417 |
| 36 | Protruding tongue (HP:0010808) | 3.03259409 |
| 37 | Febrile seizures (HP:0002373) | 2.99779791 |
| 38 | Orchitis (HP:0100796) | 2.99040073 |
| 39 | Supraventricular tachycardia (HP:0004755) | 2.97095317 |
| 40 | Increased IgE level (HP:0003212) | 2.95788846 |
| 41 | Syncope (HP:0001279) | 2.94950226 |
| 42 | Hypergammaglobulinemia (HP:0010702) | 2.93614312 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 2.93552025 |
| 44 | Heart block (HP:0012722) | 2.92179326 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 2.91992367 |
| 46 | Clumsiness (HP:0002312) | 2.91316850 |
| 47 | Areflexia of lower limbs (HP:0002522) | 2.91012323 |
| 48 | Optic neuritis (HP:0100653) | 2.88645933 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.88645933 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.88349934 |
| 51 | Rimmed vacuoles (HP:0003805) | 2.88102699 |
| 52 | Supraventricular arrhythmia (HP:0005115) | 2.85814562 |
| 53 | Vasculitis (HP:0002633) | 2.84041973 |
| 54 | Type II lissencephaly (HP:0007260) | 2.82694665 |
| 55 | Fatigue (HP:0012378) | 2.81075722 |
| 56 | Lipoatrophy (HP:0100578) | 2.80616733 |
| 57 | Subaortic stenosis (HP:0001682) | 2.77099489 |
| 58 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.77099489 |
| 59 | Eosinophilia (HP:0001880) | 2.77026457 |
| 60 | Gaze-evoked nystagmus (HP:0000640) | 2.76191343 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.74842188 |
| 62 | Recurrent skin infections (HP:0001581) | 2.74776847 |
| 63 | Prolonged QT interval (HP:0001657) | 2.73988309 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.72737023 |
| 65 | Inability to walk (HP:0002540) | 2.72076865 |
| 66 | Abnormality of midbrain morphology (HP:0002418) | 2.70239633 |
| 67 | Molar tooth sign on MRI (HP:0002419) | 2.70239633 |
| 68 | Progressive cerebellar ataxia (HP:0002073) | 2.67251923 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.67141278 |
| 70 | Fair hair (HP:0002286) | 2.65288658 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64375268 |
| 72 | Abnormality of T cells (HP:0002843) | 2.61260570 |
| 73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60930788 |
| 74 | Obstructive lung disease (HP:0006536) | 2.60930788 |
| 75 | Abnormal atrioventricular conduction (HP:0005150) | 2.60452456 |
| 76 | Dysostosis multiplex (HP:0000943) | 2.60051466 |
| 77 | Ventricular tachycardia (HP:0004756) | 2.59710462 |
| 78 | Congenital stationary night blindness (HP:0007642) | 2.58531281 |
| 79 | Pulmonary infiltrates (HP:0002113) | 2.58394298 |
| 80 | Pancreatic fibrosis (HP:0100732) | 2.58359836 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.57013913 |
| 82 | Cerebral hemorrhage (HP:0001342) | 2.52850915 |
| 83 | Hematochezia (HP:0002573) | 2.45294367 |
| 84 | Leukocytosis (HP:0001974) | 2.45127755 |
| 85 | Hyperkalemia (HP:0002153) | 2.44338949 |
| 86 | Granulocytopenia (HP:0001913) | 2.44022184 |
| 87 | Myocardial infarction (HP:0001658) | 2.43776703 |
| 88 | Left ventricular hypertrophy (HP:0001712) | 2.43454551 |
| 89 | Urticaria (HP:0001025) | 2.40952048 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 2.40630781 |
| 91 | Basal ganglia calcification (HP:0002135) | 2.40592639 |
| 92 | Dysmetric saccades (HP:0000641) | 2.40347650 |
| 93 | Broad-based gait (HP:0002136) | 2.40259663 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39821910 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.39821910 |
| 96 | Nasal polyposis (HP:0100582) | 2.38778433 |
| 97 | Inflammation of the large intestine (HP:0002037) | 2.38658526 |
| 98 | Polycythemia (HP:0001901) | 2.38469575 |
| 99 | Distal arthrogryposis (HP:0005684) | 2.38093459 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 2.37517477 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.37517477 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 2.37428833 |
| 103 | Hypoplastic ischia (HP:0003175) | 2.36654034 |
| 104 | Neck muscle weakness (HP:0000467) | 2.36574681 |
| 105 | Arterial thrombosis (HP:0004420) | 2.35194208 |
| 106 | Nephronophthisis (HP:0000090) | 2.33451618 |
| 107 | Meningitis (HP:0001287) | 2.33126919 |
| 108 | Cellulitis (HP:0100658) | 2.32798942 |
| 109 | Colitis (HP:0002583) | 2.32120533 |
| 110 | T lymphocytopenia (HP:0005403) | 2.31855963 |
| 111 | EMG: neuropathic changes (HP:0003445) | 2.31506316 |
| 112 | Gastrointestinal inflammation (HP:0004386) | 2.31212482 |
| 113 | Tubular atrophy (HP:0000092) | 2.30822624 |
| 114 | Gingival bleeding (HP:0000225) | 2.30312529 |
| 115 | Gingivitis (HP:0000230) | 2.30297484 |
| 116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29971397 |
| 117 | Abnormality of eosinophils (HP:0001879) | 2.26430359 |
| 118 | Cerebellar dysplasia (HP:0007033) | 2.25826866 |
| 119 | Myopathic facies (HP:0002058) | 2.24411003 |
| 120 | Abnormal EKG (HP:0003115) | 2.24053194 |
| 121 | Joint swelling (HP:0001386) | 2.23959132 |
| 122 | Thrombocytosis (HP:0001894) | 2.23190620 |
| 123 | Abnormal drinking behavior (HP:0030082) | 2.20171514 |
| 124 | Polydipsia (HP:0001959) | 2.20171514 |
| 125 | Generalized hypopigmentation of hair (HP:0011358) | 2.18893933 |
| 126 | Dilated cardiomyopathy (HP:0001644) | 2.17866386 |
| 127 | Abnormality of the ischium (HP:0003174) | 2.16411682 |
| 128 | Stomatitis (HP:0010280) | 2.16220692 |
| 129 | Muscular dystrophy (HP:0003560) | 2.16217656 |
| 130 | Agammaglobulinemia (HP:0004432) | 2.15760210 |
| 131 | Encephalitis (HP:0002383) | 2.15660882 |
| 132 | Decreased circulating renin level (HP:0003351) | 2.15268879 |
| 133 | Abnormality of the nasal mucosa (HP:0000433) | 2.14399159 |
| 134 | Spontaneous hematomas (HP:0007420) | 2.14077521 |
| 135 | IgG deficiency (HP:0004315) | 2.12761212 |
| 136 | Progressive inability to walk (HP:0002505) | 2.11187051 |
| 137 | Abnormality of the renal medulla (HP:0100957) | 2.10525140 |
| 138 | True hermaphroditism (HP:0010459) | 2.10298577 |
| 139 | Pelvic girdle muscle weakness (HP:0003749) | 2.09006021 |
| 140 | Renal cortical cysts (HP:0000803) | 2.06697077 |
| 141 | Frequent falls (HP:0002359) | 2.05946930 |
| 142 | Anorexia (HP:0002039) | 2.05544316 |
| 143 | Ventricular arrhythmia (HP:0004308) | 2.05376679 |
| 144 | Periodontitis (HP:0000704) | 2.04912314 |
| 145 | Ventricular fibrillation (HP:0001663) | 2.04638945 |
| 146 | Myoglobinuria (HP:0002913) | 2.04104791 |
| 147 | Muscle fiber inclusion bodies (HP:0100299) | 2.03459443 |
| 148 | Large for gestational age (HP:0001520) | 2.03042712 |
| 149 | Pheochromocytoma (HP:0002666) | 2.02678194 |
| 150 | Chest pain (HP:0100749) | 2.02655224 |
| 151 | Myotonia (HP:0002486) | 2.02243991 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01145044 |
| 153 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01145044 |
| 154 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01145044 |
| 155 | Generalized muscle weakness (HP:0003324) | 1.99611914 |
| 156 | Chorioretinal atrophy (HP:0000533) | 1.97990374 |
| 157 | Exertional dyspnea (HP:0002875) | 1.97470753 |
| 158 | Pustule (HP:0200039) | 1.96755557 |
| 159 | Severe muscular hypotonia (HP:0006829) | 1.94756215 |
| 160 | Focal seizures (HP:0007359) | 1.94531278 |
| 161 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93468768 |
| 162 | Absence seizures (HP:0002121) | 1.93308694 |
| 163 | Hypoplasia of the pons (HP:0012110) | 1.93119620 |
| 164 | Hypochromic anemia (HP:0001931) | 1.92618239 |
| 165 | Vertebral compression fractures (HP:0002953) | 1.92584758 |
| 166 | Dialeptic seizures (HP:0011146) | 1.91745074 |
| 167 | Chronic sinusitis (HP:0011109) | 1.91694627 |
| 168 | Neuroendocrine neoplasm (HP:0100634) | 1.91661939 |
| 169 | Panhypogammaglobulinemia (HP:0003139) | 1.91473142 |
| 170 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89842819 |
| 171 | Absent speech (HP:0001344) | 1.89324296 |
| 172 | Absent phalangeal crease (HP:0006109) | 1.88404083 |
| 173 | Atrioventricular block (HP:0001678) | 1.88187607 |
| 174 | Focal motor seizures (HP:0011153) | 1.88085333 |
| 175 | Abnormality of potassium homeostasis (HP:0011042) | 1.87976179 |
| 176 | Nemaline bodies (HP:0003798) | 1.86384789 |
| 177 | Furrowed tongue (HP:0000221) | 1.86312201 |
| 178 | Amaurosis fugax (HP:0100576) | 1.85349239 |
| 179 | Short chin (HP:0000331) | 1.84846724 |
| 180 | Ulnar deviation of the wrist (HP:0003049) | 1.84620550 |
| 181 | Facial diplegia (HP:0001349) | 1.83204717 |
| 182 | Bulbous nose (HP:0000414) | 1.83095093 |
| 183 | Loss of speech (HP:0002371) | 1.83034376 |
| 184 | Attenuation of retinal blood vessels (HP:0007843) | 1.82411343 |
| 185 | Partial agenesis of the corpus callosum (HP:0001338) | 1.82333436 |
| 186 | Chronic hepatic failure (HP:0100626) | 1.82086449 |
| 187 | Chronic diarrhea (HP:0002028) | 1.82072870 |
| 188 | IgM deficiency (HP:0002850) | 1.82051105 |
| 189 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.82000963 |
| 190 | Abnormality of the pons (HP:0007361) | 1.81817355 |
| 191 | Epistaxis (HP:0000421) | 1.79330347 |
| 192 | Lymphopenia (HP:0001888) | 1.78923312 |
| 193 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.77548425 |
| 194 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.77548425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.07254884 |
| 2 | MAP3K14 | 4.45730132 |
| 3 | RIPK4 | 4.04936155 |
| 4 | TYK2 | 3.59735667 |
| 5 | MAP3K13 | 3.24735312 |
| 6 | TBK1 | 3.13687256 |
| 7 | BMPR1B | 2.86323212 |
| 8 | JAK3 | 2.86029335 |
| 9 | PHKG2 | 2.83920234 |
| 10 | PHKG1 | 2.83920234 |
| 11 | ADRBK2 | 2.82407136 |
| 12 | IKBKB | 2.45870843 |
| 13 | PINK1 | 2.43952931 |
| 14 | TTN | 2.40512971 |
| 15 | ACVR1B | 2.27792506 |
| 16 | BLK | 2.24828385 |
| 17 | DAPK2 | 2.18083859 |
| 18 | JAK1 | 2.15608246 |
| 19 | MAP4K1 | 2.11105855 |
| 20 | IKBKE | 2.09685864 |
| 21 | AKT3 | 1.98794278 |
| 22 | KIT | 1.92338389 |
| 23 | FLT3 | 1.89117352 |
| 24 | IRAK4 | 1.88985616 |
| 25 | ZAP70 | 1.79906047 |
| 26 | CHUK | 1.74306196 |
| 27 | TRPM7 | 1.70367144 |
| 28 | SCYL2 | 1.67762700 |
| 29 | SYK | 1.65169020 |
| 30 | ERN1 | 1.64698064 |
| 31 | MAPKAPK3 | 1.64068227 |
| 32 | NME2 | 1.60205976 |
| 33 | FGFR4 | 1.59752715 |
| 34 | PIK3CA | 1.57640806 |
| 35 | TAOK3 | 1.56546530 |
| 36 | GRK6 | 1.53415472 |
| 37 | TXK | 1.50386758 |
| 38 | PAK3 | 1.49000328 |
| 39 | BTK | 1.45960607 |
| 40 | MAP3K12 | 1.43533583 |
| 41 | ARAF | 1.42923362 |
| 42 | INSRR | 1.39865686 |
| 43 | MARK1 | 1.39609844 |
| 44 | MYLK | 1.37940380 |
| 45 | GRK1 | 1.34288744 |
| 46 | WNK4 | 1.33113999 |
| 47 | MAP3K7 | 1.30543191 |
| 48 | ADRBK1 | 1.30511629 |
| 49 | TEC | 1.30014855 |
| 50 | RPS6KA4 | 1.24947965 |
| 51 | MKNK2 | 1.24869992 |
| 52 | PIM2 | 1.20290289 |
| 53 | PTK2B | 1.19592476 |
| 54 | NLK | 1.18161817 |
| 55 | EPHB1 | 1.17730022 |
| 56 | ZAK | 1.16399529 |
| 57 | MUSK | 1.15256291 |
| 58 | MAPK13 | 1.13929369 |
| 59 | WEE1 | 1.13896765 |
| 60 | EIF2AK1 | 1.13837673 |
| 61 | DMPK | 1.12295425 |
| 62 | MAP3K11 | 1.08117562 |
| 63 | JAK2 | 1.07882910 |
| 64 | EIF2AK3 | 1.07641410 |
| 65 | LCK | 1.07342504 |
| 66 | CSF1R | 1.06398176 |
| 67 | ITK | 1.06335545 |
| 68 | FGFR3 | 1.05606393 |
| 69 | MAP2K3 | 1.05476628 |
| 70 | BMPR2 | 1.04966545 |
| 71 | PTK6 | 1.04168707 |
| 72 | SGK2 | 1.04059379 |
| 73 | TRIB3 | 1.03617283 |
| 74 | BRSK2 | 1.01769971 |
| 75 | NEK2 | 0.98580385 |
| 76 | IRAK3 | 0.98279589 |
| 77 | MAPK12 | 0.96845951 |
| 78 | NTRK3 | 0.95931470 |
| 79 | CSK | 0.94827291 |
| 80 | TGFBR1 | 0.94566495 |
| 81 | MAP3K1 | 0.94201384 |
| 82 | EPHA3 | 0.92064395 |
| 83 | PIM1 | 0.91710120 |
| 84 | PKN1 | 0.91221816 |
| 85 | NUAK1 | 0.90831377 |
| 86 | CAMKK2 | 0.90688206 |
| 87 | MAP3K5 | 0.90110445 |
| 88 | CAMK1 | 0.88327723 |
| 89 | MAP3K10 | 0.87650844 |
| 90 | MAP2K1 | 0.84880134 |
| 91 | STK10 | 0.82868317 |
| 92 | HIPK2 | 0.82828958 |
| 93 | CAMK2A | 0.82113817 |
| 94 | MAP4K2 | 0.81354156 |
| 95 | PRKAA1 | 0.79372392 |
| 96 | OXSR1 | 0.74727056 |
| 97 | MAP3K4 | 0.73624915 |
| 98 | RET | 0.72811627 |
| 99 | LYN | 0.72768228 |
| 100 | GRK7 | 0.70824442 |
| 101 | CASK | 0.70350476 |
| 102 | CAMK2D | 0.69933007 |
| 103 | WNK1 | 0.69401815 |
| 104 | PRKCE | 0.68696704 |
| 105 | HCK | 0.68455532 |
| 106 | BCR | 0.67440332 |
| 107 | PAK6 | 0.67261712 |
| 108 | CAMK4 | 0.66796151 |
| 109 | PASK | 0.64747012 |
| 110 | CAMKK1 | 0.64034704 |
| 111 | KSR2 | 0.62990587 |
| 112 | RIPK1 | 0.61919534 |
| 113 | WNK3 | 0.61260505 |
| 114 | TESK2 | 0.61224928 |
| 115 | STK11 | 0.60978967 |
| 116 | SGK3 | 0.60487852 |
| 117 | MAP2K4 | 0.59814619 |
| 118 | NEK9 | 0.58987026 |
| 119 | KDR | 0.58952157 |
| 120 | IRAK1 | 0.58866802 |
| 121 | STK24 | 0.57864111 |
| 122 | MAPK11 | 0.57159090 |
| 123 | STK39 | 0.57035889 |
| 124 | STK38L | 0.55998679 |
| 125 | SGK494 | 0.54650100 |
| 126 | SGK223 | 0.54650100 |
| 127 | SIK2 | 0.53986602 |
| 128 | MAPKAPK2 | 0.53666755 |
| 129 | PRKG1 | 0.52285724 |
| 130 | FGR | 0.52215494 |
| 131 | LRRK2 | 0.51571584 |
| 132 | MARK3 | 0.51269315 |
| 133 | RPS6KA6 | 0.49910048 |
| 134 | STK38 | 0.49800202 |
| 135 | PRKCD | 0.49149838 |
| 136 | MELK | 0.48521361 |
| 137 | NME1 | 0.47927353 |
| 138 | DYRK3 | 0.46054568 |
| 139 | MAP3K9 | 0.45935965 |
| 140 | ROCK1 | 0.45671110 |
| 141 | CAMK2B | 0.45582760 |
| 142 | TIE1 | 0.45275867 |
| 143 | PIK3CG | 0.44455635 |
| 144 | MAP3K3 | 0.43340152 |
| 145 | PRKCQ | 0.42920957 |
| 146 | MOS | 0.42244432 |
| 147 | MAP3K8 | 0.42066684 |
| 148 | ABL2 | 0.41566390 |
| 149 | PRKACA | 0.40758055 |
| 150 | PRKAA2 | 0.40521290 |
| 151 | TNIK | 0.40431506 |
| 152 | MAPK7 | 0.40084668 |
| 153 | MAP2K6 | 0.39080329 |
| 154 | CAMK2G | 0.38266124 |
| 155 | PDK1 | 0.38246790 |
| 156 | MST4 | 0.35630848 |
| 157 | RPS6KA3 | 0.35604086 |
| 158 | FES | 0.34526032 |
| 159 | PNCK | 0.34329410 |
| 160 | PRKCG | 0.34296758 |
| 161 | RPS6KA5 | 0.33327847 |
| 162 | EGFR | 0.33160248 |
| 163 | MAPKAPK5 | 0.31451376 |
| 164 | CDC42BPA | 0.31254980 |
| 165 | SGK1 | 0.31253142 |
| 166 | PDGFRB | 0.30419373 |
| 167 | EIF2AK2 | 0.29913714 |
| 168 | MAPK4 | 0.28881938 |
| 169 | RAF1 | 0.27794338 |
| 170 | PRKCH | 0.27377497 |
| 171 | MKNK1 | 0.27092874 |
| 172 | RPS6KA1 | 0.25930567 |
| 173 | OBSCN | 0.25732297 |
| 174 | TLK1 | 0.25354518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.06894217 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.92029788 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.90983773 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.80336717 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.76276203 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75379524 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.57012072 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.54390262 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52391486 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.41735804 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.41020178 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.38976303 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36930029 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.26823118 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.20148653 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.18597746 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.18133089 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16017413 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.14415491 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.03363758 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97535129 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.97049467 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93348280 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.93224348 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.92301550 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.89700542 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88859433 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.87251814 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.85958672 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.84819008 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.82954441 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.77325555 |
| 33 | Circadian entrainment_Homo sapiens_hsa04713 | 1.77033310 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76902947 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.75437830 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.74513666 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72943159 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.71907215 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.71065540 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69736157 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 1.67937024 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 1.66947323 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61494726 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59621910 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.57949754 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52607012 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 1.49805562 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.48933299 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.48003878 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46718419 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45661662 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43842291 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 1.41290452 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.41057733 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39088313 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38803158 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37931637 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35216856 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.34512248 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.30890639 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 1.30308241 |
| 62 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.27941376 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 1.27610051 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27479901 |
| 65 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.27102340 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.26439041 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21446364 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 1.19688672 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.18924519 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17683821 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16673196 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 1.16670752 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16168622 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15691417 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15045403 |
| 76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14333268 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.13862048 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.13612403 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13029162 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12411686 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 1.07547949 |
| 82 | Long-term depression_Homo sapiens_hsa04730 | 1.07497110 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.06205019 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04227895 |
| 85 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03329552 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 1.03269268 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02983375 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02171573 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00001741 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99550084 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97613147 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.97577404 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97279537 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96537729 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92484739 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.92380533 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92055837 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91603100 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.91107869 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.90345601 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89492882 |
| 102 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89268902 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89023219 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88489230 |
| 105 | Asthma_Homo sapiens_hsa05310 | 0.85968710 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85926924 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.84133390 |
| 108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83906447 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82187770 |
| 110 | Malaria_Homo sapiens_hsa05144 | 0.81186087 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79793669 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79710238 |
| 113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78910402 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78669185 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.78605220 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77308599 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76137195 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75415745 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75266520 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74194260 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71196807 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70582058 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70005619 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69661296 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66932130 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66585739 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65050673 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64463093 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64278108 |
| 130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64136367 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63851151 |
| 132 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63668317 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59969715 |
| 134 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59163831 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.55913065 |
| 136 | Peroxisome_Homo sapiens_hsa04146 | 0.55467113 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53875388 |
| 138 | Protein export_Homo sapiens_hsa03060 | 0.53456670 |
| 139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53312188 |
| 140 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52882437 |
| 141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52810134 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51257765 |
| 143 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50383067 |
| 144 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50203540 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50154071 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49154350 |
| 147 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49014091 |
| 148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47484282 |
| 149 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46509533 |
| 150 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46061395 |
| 151 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45261936 |
| 152 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42013965 |
| 153 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41836094 |
| 154 | Platelet activation_Homo sapiens_hsa04611 | 0.41485442 |
| 155 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41331859 |
| 156 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41159401 |
| 157 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41150124 |
| 158 | Long-term potentiation_Homo sapiens_hsa04720 | 0.40841591 |
| 159 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39695322 |
| 160 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38193625 |
| 161 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38155199 |
| 162 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37967606 |
| 163 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37750724 |
| 164 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37258639 |
| 165 | Melanoma_Homo sapiens_hsa05218 | 0.36587928 |
| 166 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36001408 |
| 167 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35734284 |
| 168 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35628356 |
| 169 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34783987 |
| 170 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34252275 |
| 171 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33161622 |
| 172 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33121984 |
| 173 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33064840 |
| 174 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32978244 |
| 175 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31722161 |
| 176 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31046000 |
| 177 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.30595531 |
| 178 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30526768 |
| 179 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30488034 |
| 180 | Endocytosis_Homo sapiens_hsa04144 | 0.30418485 |
| 181 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30007291 |
| 182 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28218368 |
| 183 | DNA replication_Homo sapiens_hsa03030 | 0.27223411 |
| 184 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26139494 |

